Smart technology care for pulmonary thromboembolism patients
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether using smart technology, like apps or devices, can improve care for people with pulmonary thromboembolism (blood clots in the lungs). It aims to help patients manage their condition better and recover more smoothly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently in the hospital.
- You have been diagnosed with a blood clot in your lungs (pulmonary thromboembolism) either for the first time or you have had one before with remaining clot seen on imaging.
- You are able to use a smartphone or tablet.
- You are not pregnant or breastfeeding.
- You have not been in a similar study before and are not in another clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a smartphone app or tablet helps doctors and patients work together to prevent or manage blood clots in the legs or lungs. It is for adults in the hospital who have or are at high risk of a blood clot.
This study uses smart technology to help manage the risk of blood clots (called VTE) after you leave the hospital. It focuses on giving you tools to stay safe and healthy during your recovery.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This trial tests a computerized tool that helps doctors decide who needs prevention medicines to lower the risk of blood clots after a hospital stay. It may help reduce preventable clotting risk for people who are less mobile and have added risk factors.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.